Prothena | PRTA - Активы





Активы Изменить Дата
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Akebia Therapeutics USD 342.13M 7.53M 2026-09
ALKERMES USD 4.44B 42.4M 2026-09
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amgen USD 96.05B 409M 2026-09
Biogen USD 32.05B 32.5M 2026-09
BioMarin Pharmaceutical USD 11.57B 154.21M 2026-09
Exelixis USD 2.51B 19.26M 2026-09
Immunic USD 189.74M 165.69M 2026-03
Incyte USD 7.29B 585.39M 2026-09
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
MacroGenics USD 345.41M 127.54M 2026-06
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Neurocrine Biosciences USD 5.63B 268.3M 2026-09
Prothena USD 283.52M 19.06M 2026-09
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
Vertex Pharmaceuticals USD 32.74B 5.31B 2026-09